Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study

Objective: The effectiveness and safety of belimumab in Chinese lupus patients with different disease activities were investigated in a real-world setting. Method: Patients who received 10 mg/kg belimumab intravenously on weeks 0, 2, and 4, and then every 4 weeks on a background of standard-of-care...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Fangfang, Wu, Huaxiang, Wang, Zitao, Wu, Tong, Wu, Xue, Chen, Jie, Zhang, Danting, Bao, Chunde, Shen, Nan, Wu, Lijun, Zhu, Jing, Ye, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046515/
https://www.ncbi.nlm.nih.gov/pubmed/36979944
http://dx.doi.org/10.3390/biomedicines11030962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046515/
https://www.ncbi.nlm.nih.gov/pubmed/36979944
http://dx.doi.org/10.3390/biomedicines11030962

Ejemplares similares